
Network: Pvi, Peerview Institute For Medical Education
Show Impressions
Estimates only, not verified by show
Est. Podcast Downloads
40
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
Direct Response
Brands with CTAs
27%
Host Read %
% of host read ads
18%
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
The Bottom Line
This show has an estimated 40 audience size, runs 18% host read ads and promotes 27% of ads for direct response advertisers.
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
Fans by country:
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
Top Spenders | Est. Spent | Change | Host Read % | DR % | # of ads | Frequency | Top Shows |
|---|---|---|---|---|---|---|---|
![]() Eglis pharmaceuticals | $1 | +100.0% | 0% | 0% | 2.0ad units | Test run | |
Society of Surgical Oncology | $1 | 0.0% | 100% | 100% | 1.0ad units | Test run | |
National Ovarian Cancer Coalition | $1 | +100.0% | 100% | 100% | 1.0ad units | Test run |
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.

Nikhil I. Khushalani, MD - The Next Act of Immunotherapy in CSCC: Upgrading the Risk-Adapted Management of Resectable Disease
0:00 / 1:18#1
Run on 1x episodeUnlock show and brand data, including top ads, overall spend, and the ability to listen to ads.